| Cash flow (USD) | Q4 2026 ended May 31, 2026 | Q3 2026 ended Feb 28, 2026 | Q2 2026 ended Nov 30, 2025 | Q1 2026 ended Aug 31, 2025 | Q4 2025 ended May 31, 2025 | Q3 2025 ended Feb 28, 2025 | Q2 2025 ended Nov 30, 2024 | Q1 2025 ended Aug 31, 2024 |
|---|---|---|---|---|---|---|---|---|
| Net income | -1.15M | -1.31M | -1.32M | 2.0K | -1.54M | -1.16M | -950.0K | -1.32M |
| Depreciation and amortization | 17.0K | 20.0K | 20.0K | 20.0K | 23.0K | 21.0K | 22.0K | 21.0K |
| Stock-based compensation | 91.0K | 58.0K | 72.0K | 133.0K | 108.0K | 91.0K | 155.0K | 77.0K |
| Cash from operations | -912.0K | -1.25M | -991.0K | -268.0K | -662.0K | -1.04M | -791.0K | -1.34M |
| Cash from investing | 18.0K | 0 | -4.0K | |||||
| Cash from financing | 871.0K | 61.0K | 482.0K | 920.0K | -5.0K | 1.74M | ||
| Net change in cash | -28.0K | -1.21M | -510.0K | 654.0K | -659.0K | 686.0K | -448.0K | -1.35M |
From Biomerica Inc.'s 10-K and 10-Q filings with the SEC. Fourth quarters, and quarters where the company only reported year-to-date totals, are worked out by subtracting the earlier quarters. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read cash flow or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.